Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.685 USD | +6.43% | +5.54% | +116.62% |
03-15 | XBiotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-04 | XBiotech Inc. to Begin Constructing New R&D Facility on Its 48-Acre Campus | CI |
Sales 2022 | 4.01 5.49 | Sales 2023 | - | Capitalization | 122M 167M |
---|---|---|---|---|---|
Net income 2022 | -32M -43.79M | Net income 2023 | -24M -32.85M | EV / Sales 2022 | -27,590,059 x |
Net cash position 2022 | 217M 298M | Net cash position 2023 | 200M 274M | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.25
x | P/E ratio 2023 |
-4.94
x | Employees | 82 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.38% |
1 day | +6.43% | ||
1 week | +5.54% | ||
Current month | +12.97% | ||
1 month | +2.30% | ||
3 months | +59.57% | ||
6 months | +98.73% | ||
Current year | +116.62% |
Managers | Title | Age | Since |
---|---|---|---|
John Simard
CEO | Chief Executive Officer | 62 | 05-03-21 |
Angela Hu
DFI | Director of Finance/CFO | 40 | 14-12-31 |
Mark Ziats
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald MacAdam
BRD | Director/Board Member | 76 | 18-03-19 |
William McKenzie
BRD | Director/Board Member | 76 | 09-01-31 |
John Simard
CEO | Chief Executive Officer | 62 | 05-03-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 8.665 | +6.19% | 8 167 |
24-05-01 | 8.16 | +6.39% | 154,952 |
24-04-30 | 7.67 | -1.16% | 92,619 |
24-04-29 | 7.76 | -1.40% | 95,706 |
24-04-26 | 7.87 | -4.14% | 59,355 |
Delayed Quote Nasdaq, May 02, 2024 at 01:05 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+116.62% | 248M | |
-1.16% | 104B | |
+7.19% | 97.47B | |
+5.71% | 22.25B | |
-12.73% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.11% | 16.36B | |
+8.61% | 14.39B | |
+40.00% | 12.37B |
- Stock Market
- Equities
- XBIT Stock